Liechtenstein

5 Vaccines Approved for Use in Liechtenstein

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Approval Source: ema.europa.eu
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: ema.europa.eu
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: ema.europa.eu